Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines
出版年份 2013 全文链接
标题
Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines
作者
关键词
-
出版物
EUROPACE
Volume 16, Issue 2, Pages 162-173
出版商
Oxford University Press (OUP)
发表日期
2013-10-11
DOI
10.1093/europace/eut274
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation
- (2013) Erich Wettwer et al. CARDIOVASCULAR RESEARCH
- Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey
- (2013) A. Hernandez-Madrid et al. EUROPACE
- RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
- (2012) Harry JGM Crijns et al. BMC Cardiovascular Disorders
- Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation
- (2012) Lori D. Bash et al. CARDIOVASCULAR DRUGS AND THERAPY
- Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel
- (2012) Alexander Burashnikov et al. Circulation-Arrhythmia and Electrophysiology
- Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
- (2012) R. Pisters et al. EUROPACE
- Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
- (2012) A. J. Camm et al. EUROPACE
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- The Use of Ranolazine to Facilitate Electrical Cardioversion in Cardioversion-Resistant Patients: A Case Series
- (2012) DAVID K. MURDOCK et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Pharmacological conversion of recent-onset atrial fibrillation: A systematic review
- (2012) Magnus Heldal et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
- Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter
- (2011) I. Savelieva et al. EUROPACE
- Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections
- (2011) Hrafnhildur Stefansdottir et al. EUROPACE
- Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations
- (2011) Serge Sicouri et al. HEART RHYTHM
- Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease
- (2011) Christian Torp-Pedersen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Medical treatment of atrial fibrillation
- (2011) A. John Camm et al. Journal of Cardiovascular Medicine
- Efficacy and Safety of Vernakalant in Recent-Onset Atrial Fibrillation After the European Medicines Agency Approval: Systematic Review and Meta-Analysis
- (2011) Francesco Buccelletti et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation
- (2011) A. John Camm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation
- (2011) A. John Camm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm
- (2010) Ian G. Stiell et al. AMERICAN HEART JOURNAL
- Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation
- (2010) Craig M. Pratt et al. AMERICAN JOURNAL OF CARDIOLOGY
- Practice Patterns Among United States Cardiologists for Managing Adults With Atrial Fibrillation (from the AFFECTS Registry)
- (2010) James A. Reiffel et al. AMERICAN JOURNAL OF CARDIOLOGY
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
- (2009) Gerald V. Naccarelli et al. AMERICAN JOURNAL OF CARDIOLOGY
- The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation
- (2009) Jean-Yves Le Heuzey et al. AMERICAN JOURNAL OF CARDIOLOGY
- Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery
- (2009) Peter R. Kowey et al. Circulation-Arrhythmia and Electrophysiology
- Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation
- (2008) Denis Roy et al. CIRCULATION
- Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
- (2008) I. Savelieva et al. EUROPACE
- Role of potassium currents in cardiac arrhythmias
- (2008) U. Ravens et al. EUROPACE
- Pharmacokinetics of Novel Atrial-Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors
- (2008) Zhongping L. Mao et al. JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started